In the last 12 months, insiders at Drugs Made In America Acquisition Corp. ($DMAA) filed 16 transactions with the SEC: 8 open-market purchases totaling $0 and 2 sales totaling $0. Net insider sentiment: neutral.
Drugs Made In America Acquisition Corp. operates in the Blank checks industry (Real estate & construction sector).
Most Active Insiders
- Prasad Sridhar G. (Director) — 1 transaction totaling $0
- Drugs Made In America Acquisition LLC (TenPercentOwner) — 6 transactions totaling $0
- Worman Glenn C. (CFO) — 1 transaction totaling $0
- Do Catherine (Director) — 1 transaction totaling $0
- Stockwell Lynn (CEO and Executive COB) — 4 transactions totaling $0
View all SEC Filings for Drugs Made In America Acquisition Corp. (DMAA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | Drugs Made In America Acquisition LLC | TenPercentOwner | P | Ordinary shares | 30000 | $0.00 | 4,188,780.0000 | 8,571,429 | 0.72% | 0.35% |
| Feb. 18, 2025 | Drugs Made In America Acquisition LLC | TenPercentOwner | P | Rights to receive ordinary shares | 30000 | $0.00 | 430,000.0000 | 8,571,429 | 7.50% | 0.35% |
| Feb. 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | P | Ordinary shares | 30000 | $0.00 | 4,188,780.0000 | 8,571,429 | 0.72% | 0.35% |
| Feb. 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | P | Rights to receive ordinary shares | 30000 | $0.00 | 430,000.0000 | 8,571,429 | 7.50% | 0.35% |
| Jan. 29, 2025 | Drugs Made In America Acquisition LLC | TenPercentOwner | P | Ordinary shares | 400000 | $0.00 | 10,257,143.0000 | 8,571,429 | 4.06% | 4.67% |
| Jan. 29, 2025 | Drugs Made In America Acquisition LLC | TenPercentOwner | J | Ordinary shares | 400000 | $0.00 | 9,857,143.0000 | 8,571,429 | 3.90% | 4.67% |
| Jan. 29, 2025 | Drugs Made In America Acquisition LLC | TenPercentOwner | S | Ordinary shares | 5698363 | $0.00 | 4,158,780.0000 | 8,571,429 | 57.81% | 66.48% |
| Jan. 29, 2025 | Drugs Made In America Acquisition LLC | TenPercentOwner | P | Rights to receive ordinary shares | 400000 | $0.00 | 400,000.0000 | 8,571,429 | 9999.99% | 4.67% |
| Jan. 29, 2025 | Stockwell Lynn | CEO and Executive COB | P | Ordinary shares | 400000 | $0.00 | 10,257.1430 | 8,571,429 | 0.00% | 4.67% |
| Jan. 29, 2025 | Stockwell Lynn | CEO and Executive COB | J | Ordinary shares | 400000 | $0.00 | 9,857,143.0000 | 8,571,429 | 3.90% | 4.67% |
| Jan. 29, 2025 | Stockwell Lynn | CEO and Executive COB | S | Ordinary shares | 5698363 | $0.00 | 4,158,780.0000 | 8,571,429 | 57.81% | 66.48% |
| Jan. 29, 2025 | Stockwell Lynn | CEO and Executive COB | P | Rights to receive ordinary shares | 400000 | $0.00 | 400,000.0000 | 8,571,429 | 9999.99% | 4.67% |
| Jan. 29, 2025 | Shulgan Myron W. | Director | J | Ordinary shares | 100000 | $0.00 | 100,000.0000 | 8,571,429 | 9999.99% | 1.17% |
| Jan. 29, 2025 | Prasad Sridhar G. | Director | J | Ordinary shares | 100000 | $0.00 | 100,000.0000 | 8,571,429 | 9999.99% | 1.17% |
| Jan. 29, 2025 | Do Catherine | Director | J | Ordinary shares | 100000 | $0.00 | 100,000.0000 | 8,571,429 | 9999.99% | 1.17% |
| Jan. 29, 2025 | Worman Glenn C. | CFO | J | Ordinary shares | 100000 | $0.00 | 100,000.0000 | 8,571,429 | 9999.99% | 1.17% |